Wellington Shields & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.74M | Sell |
30,747
-70
| -0.2% | -$15.1K | 1.73% | 9 |
|
|
2026
Q1 | $6.7M | Hold |
30,817
| – | – | 1.71% | 9 |
|
|
2025
Q4 | $7.04M | Buy |
30,817
+1,375
| +5% | +$313K | 1.74% | 9 |
|
|
2025
Q3 | $6.82M | Sell |
29,442
-300
| -1% | -$61.1K | 1.78% | 9 |
|
|
2025
Q2 | $5.52M | Sell |
29,742
-715
| -2% | -$133K | 1.56% | 10 |
|
|
2025
Q1 | $6.38M | Buy |
30,457
+525
| +2% | +$102K | 2% | 7 |
|
|
2024
Q4 | $5.32M | Buy |
29,932
+295
| +1% | +$54.2K | 1.63% | 11 |
|
|
2024
Q3 | $5.85M | Buy |
29,637
+33
| +0.1% | +$6.16K | 1.78% | 8 |
|
|
2024
Q2 | $5.08M | Buy |
29,604
+14
| +0% | +$2.32K | 1.65% | 10 |
|
|
2024
Q1 | $5.39M | Buy |
29,590
+35
| +0.1% | +$6.03K | 1.81% | 8 |
|
|
2023
Q4 | $4.58M | Sell |
29,555
-1,007
| -3% | -$147K | 1.69% | 8 |
|
|
2023
Q3 | $4.56M | Buy |
30,562
+3,218
| +12% | +$472K | 1.14% | 8 |
|
|
2023
Q2 | $3.68M | Sell |
27,344
-7,341
| -21% | -$1.08M | 0.87% | 11 |
|
|
2023
Q1 | $5.53M | Buy |
34,685
+1,368
| +4% | +$209K | 1.24% | 7 |
|
|
2022
Q4 | $5.38M | Buy |
33,317
+694
| +2% | +$106K | 1.22% | 7 |
|
|
2022
Q3 | $4.38M | Sell |
32,623
-922
| -3% | -$132K | 1.91% | 9 |
|
|
2022
Q2 | $5.14M | Sell |
33,545
-28
| -0.1% | -$4.28K | 1.25% | 6 |
|
|
2022
Q1 | $5.44M | Buy |
33,573
+1,019
| +3% | +$148K | 1.79% | 7 |
|
|
2021
Q4 | $4.41M | Buy |
32,554
+597
| +2% | +$70.5K | 0.88% | 13 |
|
|
2021
Q3 | $3.45M | Sell |
31,957
-205
| -0.6% | -$23.4K | 1.2% | 17 |
|
|
2021
Q2 | $3.62M | Buy |
32,162
+1,631
| +5% | +$184K | 1.2% | 16 |
|
|
2021
Q1 | $3.3M | Buy |
30,531
+540
| +2% | +$57.8K | 1.18% | 17 |
|
|
2020
Q4 | $3.21M | Sell |
29,991
-321
| -1% | -$30.8K | 1.15% | 17 |
|
|
2020
Q3 | $2.65M | Sell |
30,312
-99
| -0.3% | -$9.32K | 1.12% | 23 |
|
|
2020
Q2 | $2.99M | Buy |
30,411
+5,060
| +20% | +$446K | 1.31% | 19 |
|
|
2020
Q1 | $1.93M | Buy |
25,351
+86
| +0.3% | +$7.33K | 1.06% | 25 |
|
|
2019
Q4 | $2.24M | Buy |
+25,265
| New | +$2.1M | 0.99% | 25 |
|
|
2019
Q3 | – | Sell |
-20,270
| Closed | -$1.47M | – | 91 |
|
|
2019
Q2 | $1.47M | Buy |
20,270
+1,190
| +6% | +$93.5K | 0.7% | 40 |
|
|
2019
Q1 | $1.54M | Buy |
19,080
+87
| +0.5% | +$7.12K | 0.78% | 36 |
|
|
2018
Q4 | $1.75M | Sell |
18,993
-329
| -2% | -$28.9K | 1% | 26 |
|
|
2018
Q3 | $1.83M | Buy |
19,322
+64
| +0.3% | +$6.07K | 0.99% | 28 |
|
|
2018
Q2 | $1.78M | Sell |
19,258
-742
| -4% | -$72.5K | 0.92% | 31 |
|
|
2018
Q1 | $1.89M | Sell |
20,000
-61
| -0.3% | -$6.7K | 1.02% | 29 |
|
|
2017
Q4 | $1.94M | Buy |
20,061
+43
| +0.2% | +$4.05K | 1.04% | 30 |
|
|
2017
Q3 | $1.78M | Buy |
20,018
+825
| +4% | +$62.8K | 0.59% | 30 |
|
|
2017
Q2 | $1.39M | Buy |
19,193
+27
| +0.1% | +$1.81K | 0.48% | 31 |
|
|
2017
Q1 | $1.25M | Sell |
19,166
-270
| -1% | -$17K | 0.38% | 31 |
|
|
2016
Q4 | $1.22M | Buy |
19,436
+25
| +0.1% | +$1.53K | 0.64% | 30 |
|
|
2016
Q3 | $1.22M | Buy |
19,411
+23
| +0.1% | +$1.49K | 0.62% | 31 |
|
|
2016
Q2 | $1.2M | Buy |
19,388
+125
| +0.6% | +$7.62K | 0.74% | 26 |
|
|
2016
Q1 | $1.1M | Buy |
19,263
+428
| +2% | +$23.9K | 0.73% | 28 |
|
|
2015
Q4 | $1.12M | Sell |
18,835
-315
| -2% | -$18.1K | 0.74% | 26 |
|
|
2015
Q3 | $1.04M | Hold |
19,150
| – | – | 0.79% | 26 |
|
|
2015
Q2 | $1.29M | Hold |
19,150
| – | – | 0.43% | 23 |
|
|
2015
Q1 | $1.12M | Buy |
19,150
+800
| +4% | +$48.3K | 0.66% | 28 |
|
|
2014
Q4 | $1.2M | Buy |
18,350
+3,100
| +20% | +$195K | 0.69% | 26 |
|
|
2014
Q3 | $881K | Sell |
15,250
-3,000
| -16% | -$167K | 0.55% | 32 |
|
|
2014
Q2 | $1.03M | Sell |
18,250
-200
| -1% | -$10.5K | 0.64% | 28 |
|
|
2014
Q1 | $948K | Hold |
18,450
| – | – | 0.6% | 34 |
|
|
2013
Q4 | $974K | Sell |
18,450
-100
| -0.5% | -$4.92K | 0.66% | 31 |
|
|
2013
Q3 | $830K | Buy |
18,550
+3,450
| +23% | +$153K | 0.66% | 36 |
|
|
2013
Q2 | $624 | Buy |
+15,100
| New | +$660K | 0.02% | 53 |
|
Other funds holding ABBV
Wellington Shields & Co's ABBV Position: Q2 2026 in Review
Wellington Shields & Co reduced its AbbVie (ABBV) stake by 0.23% in Q2 2026, selling an estimated $15.1K and leaving 30,747 shares worth $7.74M. The position accounts for 1.73% of the portfolio, ranked #9.
Wellington Shields & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Wellington Shields & Co held 30,747 shares of AbbVie worth $7.74M as of Q2 2026.
- Wellington Shields & Co sold 70 AbbVie shares in Q2 2026, an estimated $15.1K.
- AbbVie made up 1.73% of Wellington Shields & Co's portfolio in Q2 2026, its #9 holding.
- Wellington Shields & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.